Methylnaltrexone bromide methanol monosolvate

by Xinbo Zhou, Song Li, Zhibing Zheng, Xu Cai, Guoqing Li
Published 2012-03-01

Methylnaltrexone in the treatment of opioid-induced constipation

by Beverley Greenwood-Van Meerveld, Kelly M Standifer
Published 2008-12-01

Laxatives or methylnaltrexone for the management of constipation in palliative care patients

by Bridget Candy, Louise Jones, Margaret Lynn Goodman, Robyn Drake, Adrian Tookman

Opioid-Induced Constipation in Advanced Illness: Safety and Efficacy of Methylnaltrexone Bromide

by S. Bader, K. Jaroslawski, H.E. Blum, G. Becker
Published 2011-01-01

Managing opioid-induced constipation in advanced illness: focus on methylnaltrexone bromide

by Katri Elina Clemens, Eberhard Klaschik
Published 2010-02-01

Safety of oral methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain

by Rauck RL, Slatkin NE, Stambler N, Israel RJ
Published 2018-12-01

Oral methylnaltrexone does not negatively impact analgesia in patients with opioid-induced constipation and chronic noncancer pain

by Webster LR, Israel RJ
Published 2018-08-01

Methylnaltrexone for opioid-induced constipation: review and meta-analyses for objective plus subjective efficacy and safety outcomes

by Siemens W, Becker G
Published 2016-03-01

Analysis of opioid-mediated analgesia in Phase III studies of methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain

by Webster LR, Brenner DM, Barrett AC, Paterson C, Bortey E, Forbes WP
Published 2015-10-01

Optimal treatment of opioid induced constipation in daily clinical practice – an observational study

by Elisabeth C. W. Neefjes, Hanneke van der Wijngaart, Maurice J. D. L. van der Vorst, Diederik ten Oever, Hans J. van der Vliet, Aart Beeker, Christiaan A. Rhodius, Hendrik P. van den Berg, Johannes Berkhof, Henk M. W. Verheul
Published 2019-03-01

Oral methylnaltrexone is efficacious and well tolerated for the treatment of opioid-induced...

by Webster LR, Israel RJ
Published 2018-10-01

Analysis of opioid-mediated analgesia in Phase III studies of methylnaltrexone for opioid-induced...

by Webster LR, Brenner DM, Barrett AC, Paterson C, Bortey E, Forbes WP
Published 2018-06-01

Subcutaneous Methylnaltrexone for Treatment of Opioid-Induced Constipation in Cancer versus...

by Chamberlain BH, Rhiner M, Slatkin NE, Stambler N, Israel RJ
Published 2021-09-01

Attrition of methylnaltrexone treatment-emergent adverse events in patients with chronic noncancer...

by Neel Mehta, Neal E. Slatkin, Robert J. Israel, Nancy Stambler
Published 2021-09-01

The Use of Peripheral μ-Opioid Receptor Antagonists (PAMORA) in the Management of Opioid-Induced Constipation: An Update on Their Efficacy and Safety

by Pergolizzi JV Jr, Christo PJ, LeQuang JA, Magnusson P
Published 2020-03-01

Protease inhibitor-induced nausea and vomiting is attenuated by a peripherally acting, opioid-receptor antagonist in a rat model

by Mehendale Sangeeta R, Wang Chong-Zhi, Yuan Chun-Su, Aung Han H, Foo Adela, Israel Robert J
Published 2009-08-01

Isolating peripheral effects of endogenous opioids in modulating exertional breathlessness in people with moderate or severe COPD: a randomised controlled trial

by David C. Currow, Toby Hunt, Sandra Louw, Danny Eckert, Peter Allcroft, Tim H.M. To, Aine Greene, Malgorzata Krajnik, Don Mahler, Magnus Ekström
Published 2019-12-01

Emerging therapies for patients with symptoms of opioid-induced bowel dysfunction

by Leppert W
Published 2015-04-01

Peripheral Opioid Receptor Antagonists for Opioid-Induced Constipation: A Primer on Pharmacokinetic Variabilities with a Focus on Drug Interactions

by Gudin J, Fudin J
Published 2020-02-01

Repurposing FDA-approved drugs against multiple proteins of SARS-CoV-2: An in silico study

by Alfred Olaoluwa Akinlalu, Annapoorna Chamundi, Donald Terseer Yakumbur, Funmilayo I. Deborah Afolayan, Ijeoma Akunna Duru, Michael Aderibigbe Arowosegbe, Ojochenemi Aladi Enejoh
Published 2021-09-01